Inmaculada Rioja

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 411 citations · Full text

Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response

Terry Fang, Uwe Schaefer, Ingrid Mecklenbräuker et al. · The Journal of Experimental Medicine · 2012 · 164 citations · Full text

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony‐stimulating factor

Inmaculada Rioja, Fiona J. Hughes, Catriona Sharp et al. · Arthritis & Rheumatism · 2008 · 138 citations

Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells

Wenxian Fu, Júlia Farache, Susan M. Clardy et al. · eLife · 2014 · 85 citations · Full text

GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins

Robert J. Watson, Paul Bamborough, Heather Barnett et al. · Journal of Medicinal Chemistry · 2020 · 84 citations · Full text

Chemoprevention Strategy, Immunology, Molecular Biology +21